If you’re in a calorie deficit – either from dieting or while taking a weight loss drug – these exercises help direct your ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Dropping a dress size isn’t always as daunting as it seems. Experts discuss their favorite ways to set healthy and manageable ...

Veru's enobosarm showed significant body composition benefits in Phase 2b trials with semaglutide. Extension study results ...

A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy.

News research shows GLP-1 medications may help treat a wide range of conditions, from addiction and dementia to heart disease ...

U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

A high-dose form of Novo’s obesity drug led to 20% weight loss over 72 weeks. Meanwhile, Atara got a complete response letter ...

Novo Nordisk's STEP UP trial shows semaglutide 7.2 mg delivers superior weight loss and safety compared to lower doses and ...